ArticleTechnology in cancer research & treatment

Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study.

Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.